NCBI Logo
GEO Logo
   NCBI > GEO > Accession DisplayHelp Not logged in | LoginHelp
GEO help: Mouse over screen elements for information.
          Go
Series GSE160812 Query DataSets for GSE160812
Status Public on Nov 03, 2022
Title Different expression of lincRNAs between wild type and oxaliplatin resistant HepG2 cell line
Organism Homo sapiens
Experiment type Non-coding RNA profiling by high throughput sequencing
Summary We found that there were 2109 differentially expressed lincRNAs between oxaliplatin resistant and wild type HCC cells, of which 1109 were up-regulated lincRNAs and 1000 were down-regulated lincRNAs.
 
Overall design According to the construction method of drug-resistant HepG2 cells, we screened oxaliplatin resistant cells, detected the expression of lincRNA in drug-resistant cell lines and wild-type cell lines, and analyzed the up-regulated and down-regulated lincRNAs after summarizing the differentially expressed lincRNAs.
 
Contributor(s) Ma L
Citation missing Has this study been published? Please login to update or notify GEO.
Submission date Nov 04, 2020
Last update date Nov 03, 2022
Contact name Luyuan Ma Luyuan Ma
E-mail(s) miraclexxj@126.com
Phone 86-13623319263
Organization name the Third Hospital of Hebei Medical University
Street address No.68, Xiangjiang Road
City Shijiazhuang
ZIP/Postal code 050000
Country China
 
Platforms (1)
GPL24676 Illumina NovaSeq 6000 (Homo sapiens)
Samples (4)
GSM4879605 Normal1
GSM4879606 Normal2
GSM4879607 Oxa1
Relations
BioProject PRJNA674578
SRA SRP291116

Download family Format
SOFT formatted family file(s) SOFTHelp
MINiML formatted family file(s) MINiMLHelp
Series Matrix File(s) TXTHelp

Supplementary file Size Download File type/resource
GSE160812_lnc_transcripts.txt.gz 743.5 Kb (ftp)(http) TXT
SRA Run SelectorHelp
Raw data are available in SRA
Processed data are available on Series record

| NLM | NIH | GEO Help | Disclaimer | Accessibility |
NCBI Home NCBI Search NCBI SiteMap